Jiangxi Fushine Pharmaceutical Co Ltd
SZSE:300497
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangxi Fushine Pharmaceutical Co Ltd's stock price target?
Not Available
Jiangxi Fushine Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Jiangxi Fushine Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%
For the last 11 years the compound annual growth rate for Jiangxi Fushine Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 12%.